The risk of myeloma remained elevated for ankylosing spondylitis patients and was still of borderline significance for systemic sclerosis patients, although the SIR had decreased compared to the earlier part of the follow-up period (1964–1990).
← all excerpts
Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma.
1
—
—